# Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

> **NCT01056575** · PHASE1 · COMPLETED · sponsor: **Oxagen Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** OC000459

## Key facts

- **NCT ID:** NCT01056575
- **Lead sponsor:** Oxagen Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056575, "Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01056575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*